IPA-containing painkillers likely to be pulled from shelves

Published: 2011-01-13 06:56:00

Updated: 2011-01-13 06:56:00

Best-selling painkillers, Samjin Pharm's Geworin, Bayer Korea's Saridon-A and others, will face being banned in the domestic market as the Korea Food and Drug Administration (KFDA) on Tuesday ordered the manufacturers to submit the safety report on isopropylantipyrine (IPA) until March next year ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK